You are here

First Year Study Results +2.5 Bu./A. Advantage for Escalate + ILeVO at Earlier Planting

The purpose of this study was to evaluate yield and profitability differences between earlier and later planting dates with three different seed treatments providing protection against Sudden Death Syndrome (SDS).
Sudden Death Syndrome incidence increases when planting into cool, moist soil conditions early in the season. The disease infection takes place during those early vegetative growth stages, but visual symptoms are not recognized until the reproduction stages. Many times, areas that are compacted or have poor drainage can be the patches in a field where symptomology is first recognized. 
This study highlighted a difference in how ILeVO performed when comparing planting dates. The earlier planting date resulted in a 2.5 Bu./A. advantage with Beck’s Escalate™ + ILeVO over Escalate alone. Comparing Escalate alone to Escalate + ILeVO at a later planting date, only resulted in a 1.2 Bu./A. yield advantage. Therefore, earlier planting increased the yield advantage of ILeVO by 1.3 Bu./A. over planting at a later planting date. 
Click here for additional study details You can download Beck’s entire 2015 Practical Farm Research (PFR)® book here.
Beck's Hybrids PFR program conducts more than 75 different studies across multiple locations (500+ acres) to learn how different management practices and new technologies perform in field environments. Simply put, it is research focused with the farmer in mind.
Escalate™ and Practical Farm Research (PFR)® are trademarks of Beck’s Superior Hybrids, Inc. ILeVO® is a registered trademark of Bayer. Individual results may vary. 
Read more about